v3.26.1
Condensed Statement of Changes in Shareholders’ Equity (Deficit) (Unaudited) - USD ($)
Class A
Ordinary shares
Class B
Ordinary shares
Additional paid-in capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 767 [1] $ 24,233 $ (64,829) $ (39,829)
Balance (in Shares) at Dec. 31, 2025 7,666,667 [1]      
Accretion of Class A ordinary shares subject to redemption at redemption value [1] (10,453,893) (9,417,591) (19,871,484)
Net income [1] 2,861,802 2,861,802
Issuance of Class A ordinary shares to Sponsor and Underwriter $ 65 [1] 65
Issuance of Class A ordinary shares to Sponsor and Underwriter (in Shares) 645,000      
Assignment of founders shares [1] 90,300 90,300
Proceeds from sale of Private Placement Warrants, net of issuance costs [1] 1,612,825 1,612,825
Proceeds from sale of Public Warrants, net of issuance costs [1] 3,978,355 3,978,355
Proceeds from sale of Private Placement Shares, net of issuance costs [1] 4,838,480 4,838,480
Balance at Jun. 30, 2026 $ 65 $ 767 [1] 90,300 (6,620,618) (6,529,486)
Balance (in Shares) at Jun. 30, 2026 645,000 7,666,667 [1]      
Balance at Mar. 31, 2026 $ 65 $ 767 90,300 (6,518,735) (6,427,603)
Balance (in Shares) at Mar. 31, 2026 645,000 7,666,667      
Accretion of Class A ordinary shares subject to redemption at redemption value (1,959,401) (1,959,401)
Net income 1,857,518 1,857,518
Balance at Jun. 30, 2026 $ 65 $ 767 [1] $ 90,300 $ (6,620,618) $ (6,529,486)
Balance (in Shares) at Jun. 30, 2026 645,000 7,666,667 [1]      
[1] As of January 1, 2026, the Company’s Class B ordinary shares included up to 1,000,000 Founder Shares that were subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (Note 6). On January 29, 2026, the Underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,000,000 Founder Shares are no longer subject to forfeiture.